KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Crescent Capital BDC (CCAP) EBITDA (2021 - 2026)

Crescent Capital BDC filings provide 5 years of EBITDA readings, the most recent being $141.8 million for Q4 2025.

  • On a quarterly basis, EBITDA rose 180.86% to $141.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $66.9 million, a 126.11% increase, with the full-year FY2025 number at $66.9 million, up 162.67% from a year prior.
  • EBITDA hit $141.8 million in Q4 2025 for Crescent Capital BDC, up from -$24.1 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $141.8 million in Q4 2025 to a low of -$175.3 million in Q4 2024.
  • Median EBITDA over the past 5 years was -$22.9 million (2023), compared with a mean of -$10.8 million.
  • The widest YoY moves for EBITDA: up 262.29% in 2023, down 266.28% in 2023.
  • Crescent Capital BDC's EBITDA stood at $80.9 million in 2021, then increased by 21.32% to $98.2 million in 2022, then plummeted by 263.04% to -$160.1 million in 2023, then fell by 9.53% to -$175.3 million in 2024, then skyrocketed by 180.86% to $141.8 million in 2025.
  • The last three reported values for EBITDA were $141.8 million (Q4 2025), -$24.1 million (Q3 2025), and -$25.7 million (Q2 2025) per Business Quant data.